Skip to content
10-Q

Quarterly Report

ACTUATE THERAPEUTICS, INC. ACTU

0001683168-25-008323

← back to feed
Filed
Nov 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 12, 2025 23.24M sh
Shares Diluted Q3 2025 · Sep 30, 2025 21.39M sh
Shares Diluted Q3 2025 · Sep 30, 2025 20.19M sh
Shares Diluted Q3 2025 · Sep 30, 2024 10.77M sh
Shares Diluted Q3 2025 · Sep 30, 2024 4.65M sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$15.47M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$17.07M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $16.92M
Stockholders Equity Q3 2025 · Sep 30, 2025 $10.94M
Stockholders Equity Q3 2025 · Jun 30, 2025 −$2.65M
Stockholders Equity Q3 2025 · Mar 31, 2025 −$5.09M
Stockholders Equity Q3 2025 · Dec 31, 2024 $104.19K
Stockholders Equity Q3 2025 · Sep 30, 2024 $5.36M
Stockholders Equity Q3 2025 · Jun 30, 2024 −$114.26M
Stockholders Equity Q3 2025 · Mar 31, 2024 −$107.77M
Stockholders Equity Q3 2025 · Dec 31, 2023 −$99.63M
Current Liabilities Q3 2025 · Sep 30, 2025 $6.37M
Current Liabilities Q3 2025 · Dec 31, 2024 $8.8M
Total Liabilities Q3 2025 · Sep 30, 2025 $6.78M
Total Liabilities Q3 2025 · Dec 31, 2024 $9.21M
Current Assets Q3 2025 · Sep 30, 2025 $17.44M
Current Assets Q3 2025 · Dec 31, 2024 $9.21M
Total Assets Q3 2025 · Sep 30, 2025 $17.71M
Total Assets Q3 2025 · Dec 31, 2024 $9.32M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.25
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.88
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.55
Eps Diluted Q3 2025 · Sep 30, 2024 −$4.48
Eps Basic Q3 2025 · Sep 30, 2025 −$0.25
Eps Basic Q3 2025 · Sep 30, 2025 −$0.88
Eps Basic Q3 2025 · Sep 30, 2024 −$0.55
Eps Basic Q3 2025 · Sep 30, 2024 −$4.48
Sga Expense Q3 2025 · Sep 30, 2025 $3.29M
Sga Expense Q3 2025 · Sep 30, 2025 $9.64M
Sga Expense Q3 2025 · Sep 30, 2024 $1.64M
Sga Expense Q3 2025 · Sep 30, 2024 $3.61M
Rd Expense Q3 2025 · Sep 30, 2025 $2.18M
Rd Expense Q3 2025 · Sep 30, 2025 $8.16M
Rd Expense Q3 2025 · Sep 30, 2024 $3.76M
Rd Expense Q3 2025 · Sep 30, 2024 $14.99M
Net Income Q3 2025 · Sep 30, 2025 −$5.41M
Net Income Q3 2025 · Sep 30, 2025 −$17.67M
Net Income Q3 2025 · Jun 30, 2025 −$5.95M
Net Income Q3 2025 · Mar 31, 2025 −$6.32M
Net Income Q3 2025 · Sep 30, 2024 −$5.97M
Net Income Q3 2025 · Sep 30, 2024 −$20.84M
Net Income Q3 2025 · Jun 30, 2024 −$6.57M
Net Income Q3 2025 · Mar 31, 2024 −$8.3M
Operating Income Q3 2025 · Sep 30, 2025 −$5.47M
Operating Income Q3 2025 · Sep 30, 2025 −$17.81M
Operating Income Q3 2025 · Sep 30, 2024 −$5.39M
Operating Income Q3 2025 · Sep 30, 2024 −$18.6M